Ad Header



The Pulse of the Pharmaceutical Industry

Egalet says drug less likely to be abused than other painkillers

Written by: | | Dated: Monday, June 29th, 2015

Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold.

A study showed recreational opioid users did not like and were less prone to snort the company’s painkiller, Egalet-001, than MS Contin.

Egalet’s study results come a week before a panel of experts advising the U.S. Food and Drug Administration discuss if reformulated versions of opioids and other painkillers are less likely to be abused.



(Reporting by Vidya L Nathan in Bengaluru; Editing by Savio D’Souza)

Source: Reuters

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom